DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 189 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $12,810,000 | -52.4% | 635,400 | -11.8% | 0.06% | -53.7% |
| Q2 2021 | $26,885,000 | +73.4% | 720,400 | +18.8% | 0.12% | +68.1% |
| Q1 2021 | $15,507,000 | -70.3% | 606,439 | -74.4% | 0.07% | -71.7% |
| Q4 2020 | $52,128,000 | +164.2% | 2,366,225 | +120.3% | 0.25% | +58.8% |
| Q1 2020 | $19,727,000 | -28.9% | 1,073,881 | -14.8% | 0.16% | +9.6% |
| Q4 2019 | $27,763,000 | +40.4% | 1,260,216 | -6.7% | 0.15% | +62.2% |
| Q1 2019 | $19,778,000 | +141171.4% | 1,350,000 | +224900.0% | 0.09% | – |
| Q1 2015 | $14,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |